期刊文献+

急性ST段抬高型心肌梗死合并射血分数保留的心力衰竭患者急诊经皮冠状动脉介入治疗术中无复流的影响因素分析 被引量:28

Predictive factors of no flow during percutaneous coronary intervention in patients of heart failure with preserved ejection fraction with ST-segment elevation myocardial infarction
下载PDF
导出
摘要 目的 探讨急性ST段抬高型心肌梗死(ST-segment elevation myocardial infarction,STEMI)合并射血分数保留的心力衰竭(heart failure with preserved ejection fraction,HFpEF)患者行急诊经皮冠状动脉介入术(primary percutaneous coronary intervention,PPCI),术中发生无复流的影响因素.方法 连续选取2017年1月至2019年1月就诊于首都医科大学附属北京安贞医院急诊科并行急诊PCI治疗的STEMI合并HFpEF患者326例,按照急诊PCI术中血流情况,分为正常复流组(255例)和无复流组(71例).比较两组的临床资料,分析无复流发生的影响因素.结果 合并HFpEF的STEMI患者,PPCI术后无复流发生率为21.8%(71/326),两组之间急诊收缩压(SBP)[(113.75±23.27)mm Hg比(127.84±34.58)mm Hg,P=0.046]、即刻血糖水平[(14.32±6.75)mmol/L比(9.17±7.50)mmol/L,P=0.038]、发病到再灌注时间[(118.07±41.35)min比(9.74±39.23)min,P=0.037]、球囊扩张次数(12.5%比10.1%,P=0.042)差异均有统计学意义(P<0.05);经多因素Logistic回归分析显示,急诊SBP(OR=1.089,95%CI 0.746~18.247,P=0.031)、球囊扩张次数(OR=1.980,95%CI 0.883~1.087,P=0.039)、发病至再灌注时间(OR=2.985,95%CI 0.064~0.982,P=0.048)是急诊PCI术中无复流发生的危险因素.结论 合并EFpHF合并STEMI患者行PPCI后无复流发生与入院收缩压、球囊扩张次数、发病至再灌注时间具有相关性. Objective To investigate the predictive factors of no flow during percutaneous coronary intervention in patients of heart failure with preserved ejection fraction(EFpHF)with ST-segment elevation myocardial infarction(STEMI).Methods Data of STEMI patients of EFpHF treated with PPCI were collected from Jan 2017to Jan 2019 and the patients were divided into the no-flow group(n=71)and the normal blood flow group(n=255)according to the condition of thrombolysis in myocardial infarction(TIMI)flow grade and TIMI myocardial perfusion grade(TMPG).Compared to analyze the risk factors related to no-retlow.Multivariable Logistic regression analysis was used to identify the independent no-reflow predictors of the model group and then we designed a score according to the odds ratio on Logistic regression analysis.Results The no-reflow phenomenon was found in 71(21.8%)of 326 patients.Compared to the normal flow group,the SBP](113.75±23.27)mmHgvs.(127.84±34.58)mm Hg,P=0.046],Glu[(14.32±6.75)mmol/L vs.(9.17±7.50)mmol/L,P=0.038],pain to balloon time[(118.07±41.35)min vs.(99.74±39.23)min,P=0.037]and times of balloon dilatation(12.5%vs.10.1%,P=0.042)were significantly different.Multivariate Logistic regression analysis demonstrated that SBP(R=1.089,95%CI 0.746-18.247,P=0.031),times of balloon dilatation(OR=1.980,95% CI 0.883-1.087,P=0.039)and pain to balloon time(R=2.985,95%CI,0.064-0.982,P=0.048)were independent predictors of no-reflow in the EFpHF patients with STEMI after PCI.Conclusion This study demonstrates that SBP,times of balloon dilatation and pain to balloon time were independent predictors of noreflow in the EFpHF patients with STEMI after PCI.
作者 熊永红 王静 李雪玲 刘娜 金泽宁 XIONG Yong-hong;WANG Jing;LI Xue-ling;LIU Na;JIN Ze-ning(Department of Cardiology,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China;Department of Emergency,Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,China;Department of Cardiology,Beijing Fengtai Hospital,Beijing 100071,China)
出处 《中国心血管病研究》 CAS 2020年第3期227-231,共5页 Chinese Journal of Cardiovascular Research
关键词 急性心肌梗死 射血分数保留的心力衰竭 经皮冠状动脉介入术 无复流 Acute myocardial infarction Heart failure with preserved ejection fraction Percutaneous coronary intervention No flow
  • 相关文献

参考文献7

二级参考文献17

  • 1Shanmugam G,LégaréJF.Revascularization for ischaemic car-diomyopathy.Curr Opin Cardiol,2008,23:148-152.
  • 2Kunadian V,Pugh A,Zaman AG,et al.Percutaneous coronaryintervention among patients with left ventricular systolic dysfunc-tion:a review and meta-analysis of 19 clinical studies.Coron Ar-tery Dis,2012,23:469-479.
  • 3Allman KC,Shaw LJ,Hachamovitch R,et al.Myocardial via-bility testing and impact of revascularization on prognosis in pa-tients with coronary artery disease and left ventricular dysfunc-tion:a meta-analysis.J Am Coll Cardiol,2002,39:1151-1158.
  • 4Cleland JGF,Freemantle N,Ball SG,et al.The heart failure re-vascularization trial(HEART):rationale design and methodolo-gy.Eur J Heart Fail,2003,5:295-303.
  • 5The VA coronary artery bypass surgery cooperative study group.Eighteen-year follow-up in the veterans affairs cooperative study ofcoronary artery bypass surgery for stable angina.Circulation,1992,86:121-130.
  • 6Testa L,Van Gaal WJ,Biondi Zoccai GG,et al.Myocardial in-farction after percutaneous coronary intervention:a meta-analysisof troponin elevation applying the new universal definition.QJM,2009,102:369-378.
  • 7Mitropoulos FA,Elefteriades JA.Myocardial revascularization asa therapeutic strategy in the patient with advanced ventriculardysfunction.Heart Fail Rev,2001,6:163-175.
  • 8Rahimi K,Banning AP,Cheng AS,et al.Prognostic value ofcoronary revascularization related myocardial injury:a cardiacmagnetic resonance imaging study.Heart,2009,95:1937-1943.
  • 9Jia-hui LI Peng YANG Ai-li LI Yong WANG Yuan-nan KE Xian-lun LI.Cardioprotective effect of liposomal prostaglandin E1 on a porcine model of myocardial infarction reperfusion no-reflow[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2011,12(8):638-643. 被引量:27
  • 10王长华,陈韵岱,杨新春,王乐丰,王红石,孙志军,刘宏斌,陈练.急性心肌梗死急诊介入后无复流的预测模型[J].中华急诊医学杂志,2011,20(11):1170-1173. 被引量:19

共引文献153

同被引文献287

引证文献28

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部